# Amarin Corp Plc\\uk: filings

AMRN · Nasdaq · CIK 897448 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amrn.md) · [Financials](/companies/amrn/financials.md) · [Filings](/companies/amrn/filings.md) · [Insiders](/companies/amrn/insiders.md)

## Reports and events: 423 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 561, 8-K 234, 3 50, SC 13D/A 50, 10-Q 48, 6-K 42, DEFA14A 20, DFAN14A 18, 10-K 16, DEF 14A 16, 424B3 15, CT ORDER 14, EFFECT 14, SC 13G/A 14, UPLOAD 14, 424B5 13, CORRESP 11, S-8 11, SC 13G 8, 4/A 7, ARS 7, PRE 14A 7, SC 13D 6, POS AM 5, 8-K/A 4, S-3 4, S-3ASR 4, 10-K/A 3, F-6 3, F-6EF 3, PRER14A 3, PRRN14A 3, 20-F 2, 3/A 2, DEFC14A 2, PREC14A 2, SCHEDULE 13D/A 2, 144 1, 20-F/A 1, D 1, DEL AM 1, F-1 1, F-1/A 1, F-3 1, F-6 POS 1, FWP 1, NT 20-F 1, S-3/A 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 07:05 ET | [10-Q](/filings/0001193125-26-435082.md) | Quarterly report, period 2026-09-30 | 0001193125-26-435082 |
| 2026-10-28 | 07:05 ET | [8-K](/filings/0001193125-26-435081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-435081 |
| 2026-08-27 | 18:56 ET | [SCHEDULE 13D/A](/filings/0000899140-26-000972.md) | Ownership report, active investor, amended | 0000899140-26-000972 |
| 2026-07-29 | 16:30 ET | [10-Q](/filings/0001193125-26-323845.md) | Quarterly report, period 2026-06-30 | 0001193125-26-323845 |
| 2026-07-29 | 16:30 ET | [8-K](/filings/0001193125-26-323841.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323841 |
| 2026-05-15 | 21:30 ET | [8-K](/filings/0001193125-26-224771.md) | 5.07 Shareholder vote results | 0001193125-26-224771 |
| 2026-04-29 | 07:06 ET | [10-Q](/filings/0001193125-26-188940.md) | Quarterly report, period 2026-03-31 | 0001193125-26-188940 |
| 2026-04-29 | 07:05 ET | [8-K](/filings/0001193125-26-188935.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-188935 |
| 2026-04-10 | 17:00 ET | [DEF 14A](/filings/0001193125-26-151417.md) | Proxy statement, period 2026-04-10 | 0001193125-26-151417 |
| 2026-03-27 | 17:00 ET | [8-K](/filings/0001193125-26-129334.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-129334 |
| 2026-03-02 | 17:31 ET | [10-K](/filings/0001193125-26-085818.md) | Annual report, period 2025-12-31 | 0001193125-26-085818 |
| 2026-02-25 | 07:05 ET | [8-K](/filings/0001193125-26-068511.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-068511 |
| 2026-01-08 | 07:05 ET | [8-K](/filings/0001193125-26-006992.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-006992 |
| 2025-10-29 | 07:05 ET | [10-Q](/filings/0001193125-25-254621.md) | Quarterly report, period 2025-09-30 | 0001193125-25-254621 |
| 2025-10-29 | 07:05 ET | [8-K](/filings/0001193125-25-254620.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-254620 |
| 2025-10-22 | 17:00 ET | [8-K](/filings/0001193125-25-246973.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-246973 |
| 2025-07-30 | 07:05 ET | [10-Q](/filings/0000950170-25-099879.md) | Quarterly report, period 2025-06-30 | 0000950170-25-099879 |
| 2025-07-30 | 07:05 ET | [8-K](/filings/0000950170-25-099878.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099878 |
| 2025-07-03 | 20:00 ET | [8-K/A](/filings/0000950170-25-093444.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-093444 |
| 2025-06-24 | 07:05 ET | [8-K](/filings/0000950170-25-089218.md) | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-089218 |
| 2025-05-15 | 17:00 ET | [8-K](/filings/0000950170-25-072817.md) | 5.07 Shareholder vote results | 0000950170-25-072817 |
| 2025-05-07 | 07:05 ET | [10-Q](/filings/0000950170-25-064981.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064981 |
| 2025-05-07 | 07:05 ET | [8-K](/filings/0000950170-25-064980.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064980 |
| 2025-04-29 | 16:20 ET | [8-K](/filings/0000950170-25-060165.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-060165 |
| 2025-04-10 | 07:30 ET | [DEF 14A](/filings/0000950170-25-052674.md) | Proxy statement, period 2025-05-13 | 0000950170-25-052674 |
| 2025-04-09 | 07:35 ET | [8-K](/filings/0000950170-25-052307.md) | 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-052307 |
| 2025-04-07 | 07:40 ET | [8-K](/filings/0000950170-25-051353.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-051353 |
| 2025-03-28 | 16:45 ET | [8-K](/filings/0000950170-25-046873.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-046873 |
| 2025-03-25 | 20:37 ET | [SCHEDULE 13D/A](/filings/0000899140-25-000466.md) | Ownership report, active investor, amended | 0000899140-25-000466 |
| 2025-03-12 | 07:05 ET | [10-K](/filings/0000950170-25-037620.md) | Annual report, period 2024-12-31 | 0000950170-25-037620 |
| 2025-03-12 | 07:05 ET | [8-K](/filings/0000950170-25-037618.md) | 2.02 Results of operations; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-037618 |
| 2024-12-18 | 16:15 ET | [8-K](/filings/0000950170-24-137894.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-137894 |
| 2024-11-22 | 16:49 ET | [8-K](/filings/0000950170-24-130263.md) | 3.01 Delisting notice | 0000950170-24-130263 |
| 2024-10-30 | 16:10 ET | [10-Q](/filings/0000950170-24-118990.md) | Quarterly report, period 2024-09-30 | 0000950170-24-118990 |
| 2024-10-30 | 16:10 ET | [8-K](/filings/0000950170-24-118988.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-118988 |
| 2024-10-07 | 16:15 ET | [8-K](/filings/0000950170-24-113227.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-113227 |
| 2024-07-31 | 07:05 ET | [8-K](/filings/0000950170-24-088234.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-088234 |
| 2024-07-31 | 07:05 ET | [10-Q](/filings/0000950170-24-088233.md) | Quarterly report, period 2024-06-30 | 0000950170-24-088233 |
| 2024-07-29 | 17:30 ET | [8-K](/filings/0000950170-24-087391.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-087391 |
| 2024-06-04 | 07:30 ET | [8-K](/filings/0000950170-24-068298.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-068298 |
| 2024-05-29 | 20:29 ET | [8-K](/filings/0000950170-24-065585.md) | 3.01 Delisting notice | 0000950170-24-065585 |
| 2024-05-01 | 07:10 ET | [8-K](/filings/0000950170-24-050889.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-050889 |
| 2024-05-01 | 07:05 ET | [10-Q](/filings/0000950170-24-050886.md) | Quarterly report, period 2024-03-31 | 0000950170-24-050886 |
| 2024-04-22 | 12:54 ET | [8-K](/filings/0000950170-24-046290.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-046290 |
| 2024-04-03 | 08:00 ET | [8-K](/filings/0000950170-24-040675.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-040675 |
| 2024-03-04 | 08:00 ET | [DEF 14A](/filings/0000950170-24-024353.md) | Proxy statement, period 2024-04-18 | 0000950170-24-024353 |
| 2024-02-29 | 07:06 ET | [10-K](/filings/0000950170-24-022636.md) | Annual report, period 2023-12-31 | 0000950170-24-022636 |
| 2024-02-29 | 07:05 ET | [8-K](/filings/0000950170-24-022635.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-022635 |
| 2024-01-26 | 07:00 ET | [8-K](/filings/0000950170-24-007688.md) | 3.01 Delisting notice | 0000950170-24-007688 |
| 2024-01-10 | 07:00 ET | [8-K](/filings/0000950170-24-003511.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-003511 |

Page 1 of 9. [Older](/companies/amrn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:23 ET. No prices; not investment advice.